S&P 500 Futures
(0.27%) 5 145.50 points
Dow Jones Futures
(0.16%) 38 502 points
Nasdaq Futures
(0.43%) 17 923 points
Oil
(-0.63%) $83.32
Gas
(2.24%) $1.966
Gold
(-0.14%) $2 343.90
Silver
(0.01%) $27.54
Platinum
(2.80%) $947.90
USD/EUR
(-0.06%) $0.934
USD/NOK
(-0.12%) $11.01
USD/GBP
(-0.29%) $0.798
USD/RUB
(1.85%) $93.57

实时更新: Millendo Therapeutics Inc [MLND]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
最后更新时间28 Jun 2021 @ 12:00

-5.36% $ 1.060

Live Chart Being Loaded With Signals

Commentary (28 Jun 2021 @ 12:00):

Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing novel treatments for orphan endocrine diseases in the United States...

Stats
今日成交量 1.91M
平均成交量 140 975
市值 11.15M
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
ATR14 $0.0940 (8.87%)
Insider Trading
Date Person Action Amount type
2020-06-22 Nuechterlein Carole Buy 12 000 Stock Option (right to buy)
2020-06-22 Howe John P Md Buy 12 000 Stock Option (right to buy)
2020-06-22 Gallagher Carol Giltner Buy 12 000 Stock Option (right to buy)
2020-06-22 Nichol Geoffrey Buy 12 000 Stock Option (right to buy)
2020-06-22 Hindman James M. Buy 12 000 Stock Option (right to buy)
INSIDER POWER
0.00
Last 34 transactions
Buy: 816 539 | Sell: 0

音量 相关性

長: -0.37 (neutral)
短: 0.79 (moderate)
Signal:(35.927) Neutral

Millendo Therapeutics Inc 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Millendo Therapeutics Inc 相关性 - 货币/商品

The country flag 0.64
( weak )
The country flag -0.17
( neutral )
The country flag 0.00
( neutral )
The country flag 0.44
( neutral )
The country flag -0.71
( moderate negative )
The country flag -0.61
( weak negative )

Millendo Therapeutics Inc 财务报表

Annual 2020
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-28.95
FY 2020
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-28.95
FY 2019
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-48.75
FY 2018
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-263.70

Financial Reports:

No articles found.

Millendo Therapeutics Inc

Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing novel treatments for orphan endocrine diseases in the United States. Its lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist for the treatment of vasomotor symptoms in menopausal women. The company is headquartered in Ann Arbor, Michigan.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。